nafamostat has been researched along with Endophthalmitis in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, T | 1 |
| Inatomi, Y | 1 |
| Yonehara, T | 1 |
| Fujioka, S | 1 |
| Hashimoto, Y | 1 |
| Hirano, T | 1 |
| Uchino, M | 1 |
1 review available for nafamostat and Endophthalmitis
| Article | Year |
|---|---|
[A patient with Vibrio vulnificus meningoencephalitis].
Topics: Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamidines; Endophthalmitis; Fishes; Foodb | 2005 |